SANDOZ

SANDOZ is a global leader in generic pharmaceuticals and biosimilars. As a division of Novartis, SANDOZ focuses on providing high-quality, affordable medications that are essential for patients around the world. The company's mission is to improve access to medicine by delivering innovative generics and unique pharmaceutical solutions that cater to diverse healthcare needs.

History

SANDOZ was founded in 1886 by Friedrich E. Sandoz as a small chemical company in Basel, Switzerland. The company initially focused on the production of dyes and synthetic products. Over the decades, SANDOZ evolved, moving into pharmaceuticals and bioengineering. In 1996, SANDOZ merged with Ciba-Geigy to form Novartis. Since then, SANDOZ has expanded significantly, becoming a global player in the generics and biosimilars market, with operations in more than 160 countries.

Product Range

SANDOZ offers a wide array of products that include generic medicines, biosimilars, and over-the-counter medications. The product portfolio spans multiple therapeutic areas, such as cardiovascular, oncology, dermatology, and central nervous system disorders. SANDOZ focuses on ensuring its products are affordable without compromising quality, making healthcare more accessible for all.

Innovation and Technology

SANDOZ places a strong emphasis on innovation and technology in the development of its products. The company invests significantly in research and development to enhance its manufacturing processes and create new, patent-free pharmaceuticals. SANDOZ is at the forefront of developing biosimilars, which are biologic products highly similar to an already approved reference product, allowing for greater patient access to essential therapies.

Market Presence

With a significant presence in over 160 markets, SANDOZ is recognized as one of the leading companies in the global generics industry. The company has strategically positioned itself in both established and emerging markets, capitalizing on the increasing demand for cost-effective medications. SANDOZ is committed to expanding its market reach through partnerships, acquisitions, and tailoring its offerings to meet local healthcare needs.

Commitment

SANDOZ is committed to providing high-quality, affordable medications while adhering to the highest standards of ethical conduct and regulatory compliance. The company fosters a culture of integrity, transparency, and respect, ensuring the trust of patients, healthcare professionals, and other stakeholders. SANDOZ collaborates closely with healthcare systems and organizations to enhance patient outcomes and access to essential therapies.

Sustainability Efforts

SANDOZ recognizes its responsibility to act sustainably and strives to minimize its environmental impact. The company's sustainability initiatives focus on reducing carbon emissions, improving resource efficiency, and promoting sustainable practices throughout its supply chain. SANDOZ is dedicated to social responsibility, engaging in numerous community and health initiatives to support improved health outcomes globally.

Conclusion

SANDOZ has established itself as a cornerstone in the global pharmaceutical landscape by combining affordability with high quality. With a rich history, a diverse product range, and a strong commitment to innovation and sustainability, SANDOZ continues to advance its mission to improve patient access to essential medications worldwide. The company's ongoing efforts to enhance healthcare and its dedication to social responsibility position it as a leader in the generics market for years to come.